Literature DB >> 19681857

A population-based study of acute medical conditions associated with bullous pemphigoid.

S M Langan1, R Hubbard, K Fleming, J West.   

Abstract

BACKGROUND: Bullous pemphigoid is associated with poorly understood dramatically increased early mortality rates.
OBJECTIVES: To assess the incidence of acute events predisposing to early mortality.
METHODS: Computerized medical records from the Health Improvement Network, a large population-based U.K. general practice database, were used to conduct a cohort analysis. Outcome measures were incidence rates of myocardial infarction, pulmonary embolism, pneumonia and sepsis compared with a matched control population.
RESULTS: People with bullous pemphigoid were three times as likely to develop pneumonia, adjusted rate ratio 2.94 [95% confidence interval (CI) 2.01-4.31] or pulmonary embolism, adjusted rate ratio 3.12 (95% CI 1.37-7.12) compared with matched controls. No statistically significant increase was seen for myocardial infarction, adjusted rate ratio 1.24 (95% CI 0.66-2.33), or sepsis, adjusted rate ratio 2.02 (95% CI 0.78-5.21).
CONCLUSIONS: The risk of pulmonary embolism and pneumonia is increased following a diagnosis of bullous pemphigoid. It may be possible to reduce associated mortality through considering prophylaxis with either antithromboembolic measures or antibiotic therapy and vaccination.

Entities:  

Mesh:

Year:  2009        PMID: 19681857     DOI: 10.1111/j.1365-2133.2009.09350.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  8 in total

Review 1.  Bullous pemphigoid: An immune disorder related to aging (Review).

Authors:  Maria Ludovica Deotto; Alice Spiller; Alvise Sernicola; Mauro Alaibac
Journal:  Exp Ther Med       Date:  2021-11-15       Impact factor: 2.447

2.  Enhanced tissue factor expression by blood eosinophils from patients with hypereosinophilia: a possible link with thrombosis.

Authors:  Massimo Cugno; Angelo V Marzano; Maurizio Lorini; Vincenzo Carbonelli; Alberto Tedeschi
Journal:  PLoS One       Date:  2014-11-06       Impact factor: 3.240

3.  Tissue Factor in Dermatitis Herpetiformis and Bullous Pemphigoid: Link between Immune and Coagulation System in Subepidermal Autoimmune Bullous Diseases.

Authors:  Agnieszka Zebrowska; Malgorzata Wagrowska-Danilewicz; Marian Danilewicz; Joanna Wieczfinska; Ewa Pniewska; Michal Zebrowski; Elzbieta Waszczykowska; Anna Wozniacka; Makandjou-Ola Eusebio; Miroslawa Pietruczuk; Rafal Pawliczak
Journal:  Mediators Inflamm       Date:  2015-12-29       Impact factor: 4.711

4.  Validation study of bullous pemphigoid and pemphigus vulgaris recording in routinely collected electronic primary healthcare records in England.

Authors:  Monica S M Persson; Karen E Harman; Yana Vinogradova; Sinead M Langan; Julia Hippisley-Cox; Kim S Thomas; Sonia Gran
Journal:  BMJ Open       Date:  2020-07-14       Impact factor: 2.692

Review 5.  Coagulation and Skin Autoimmunity.

Authors:  Massimo Cugno; Alessandro Borghi; Simone Garcovich; Angelo Valerio Marzano
Journal:  Front Immunol       Date:  2019-06-20       Impact factor: 7.561

Review 6.  New Insights Into the Pathogenesis of Bullous Pemphigoid: 2019 Update.

Authors:  Giovanni Genovese; Giovanni Di Zenzo; Emanuele Cozzani; Emilio Berti; Massimo Cugno; Angelo Valerio Marzano
Journal:  Front Immunol       Date:  2019-07-02       Impact factor: 7.561

7.  Assessment of the Characteristics and Associated Factors of Infectious Complications in Bullous Pemphigoid.

Authors:  Jia Chen; Xuming Mao; Wenling Zhao; Bingjie Zhang; Xinyi Chen; Chenyang Yu; Zehui Zheng; Hongzhong Jin; Li Li
Journal:  Front Immunol       Date:  2020-07-23       Impact factor: 7.561

Review 8.  Bullous Pemphigoid: Trigger and Predisposing Factors.

Authors:  Francesco Moro; Luca Fania; Jo Linda Maria Sinagra; Adele Salemme; Giovanni Di Zenzo
Journal:  Biomolecules       Date:  2020-10-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.